← Leaderboards
Pedro Mateu-Gelabert
National Development And Research Institutes, Inc.
$5,944,655
Attributed
$9,736,286
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2009–20$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,736,286 · 4
By mechanism
R01$9,322,961 · 3
R21$413,325 · 1
Top collaborators
- Honoria M Guarino5 shared
- Kristen M Marks5 shared
- Travis Wendel2 shared
Most similar at National Development And Research Institutes, Inc.
Same institution · by research overlap
- Honoria M Guarino$2,748,031
- Alexander S Bennett$5,812,434
- Luther Elliott$5,661,015
- Camila Gelpi-Acosta$611,815
- Michelle C Acosta$1,739,580
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventBaseDrug UsageInfectionHepatitis CHigh RiskRisk BehaviorsPharmaceutical PreparationsPublic Health RelevanceReportingParticipantHeroinHiv/HcvHiv InfectionsInjecting Drug UserPreventionDesignInjection Of Therapeutic AgentInnovationHepatitis C VirusBiologicalGossypiumEpidemicEquipment
Grant awards (17)
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$693,559
R01 · FY2020 · DA · contact PI
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$534,162
R01 · FY2020 · DA · contact PI
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$661,249
R01 · FY2019 · DA · contact PI
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$554,667
R01 · FY2019 · DA · contact PI
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$739,640
R01 · FY2018 · DA · contact PI
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$557,431
R01 · FY2018 · DA · contact PI
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$746,948
R01 · FY2017 · DA · contact PI
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$571,298
R01 · FY2017 · DA · contact PI
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids$550,788
R01 · FY2017 · DA · contact PI
The Staying Safe Intervention: Preventing HCV among Young Opioid Injectors$761,598
R01 · FY2016 · DA · contact PI
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids$608,005
R01 · FY2016 · DA · contact PI
Accessible Care Intervention for Engaging People who Inject Illicit Drugs (PWID) in Hepatitis C Care$594,712
R01 · FY2016 · DA · contact PI
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids$580,906
R01 · FY2015 · DA · contact PI
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids$613,713
R01 · FY2014 · DA · contact PI
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids$554,285
R01 · FY2013 · DA · contact PI
Staying Safe: Training IDUs in Strategies to Avoid HIV and HCV Infection$187,875
R21 · FY2010 · DA · contact PI
Staying Safe: Training IDUs in Strategies to Avoid HIV and HCV Infection$225,450
R21 · FY2009 · DA · contact PI